![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 11, 7619-7625, March 17, 2000
B Protein-DNA Complex
Varies with DNA-binding Site Sequence*
From the Department of Molecular Biology, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert, Ann Arbor, Michigan 48105
| |
ABSTRACT |
|---|
|
|
|---|
Transcriptional regulation of many immune
responsive genes is under the control of the transcription factor
NF- The transcription factor NF- The structures of the p50, p52, p65 homodimer, and p50/p65 heterodimer
protein-DNA complexes have been reported (13-17) and have provided a
great deal of insight into the mechanisms of specificity of these
protein-DNA interactions. It is clear that there are many direct
contacts between the protein and DNA in the DNA-binding domain that
afford specificity to a consensus DNA-binding site. However, there are
still many questions about how the observed structures relate to
transcriptional activity. Although the structures reported show
differences in the DNA-binding domain, it is unclear if there are any
changes in the DNA-binding domain when the protein is bound to
different DNA-binding sites. These structures were solved with a
limited number of DNA sequences, so any changes in complex structure
that depend on the DNA sequence in the site cannot be defined.
Understanding these changes in structure are particularly interesting
as the residues that interact with the DNA in a sequence specific
manner are found in a portion of the protein that is likely to be
flexible owing to its location at the end of a Using both nitrocellulose filter binding and fluorescence polarization,
the apparent dissociation constants for protein-DNA site interactions
were determined under various conditions. This analysis has identified
several interesting aspects of the NF- Protein Expression and Purification--
The GSTp50 and GSTp65
prokaryotic expression plasmids were a generous gift of Drs. Neal
Perkins and Gary Nabel (18). GST fusion proteins were expressed and
purified essentially as described by Perkins et al. (18).
Briefly, cells were grown in LB with 100 µg/ml ampicillin for 3-5 h
and induced with 1 to 3 mM
isopropyl-1-thio- DNA Binding Competition Assay--
Protein-DNA complex formation
was measured by the method of Riggs et. al. (20) as
described briefly below. DNA probe (32P- Fluorescence Polarization DNA Binding
Experiments--
Oligonucleotides for the Fluorescence Resonance Energy Transfer Measurement for DNA
Deformation--
DNA structure change was measured using
oligonucleotide-binding sites labeled with both fluorescein and
rhodamine at opposite ends using the same procedure as described above,
except a rhodamine (Molecular Probes) labeled oligonucleotide was used
instead of reannealing with an unlabeled oligonucleotide. A binding
site length of 18 base pairs was used because some energy transfer was
observed in the unbound DNA which was significantly increased in the
presence of TATA-binding protein (TBP) in substrate containing the
TATA-binding site. Fluorescence measurements were made using an
SLM-Aminco SPF-500C spectrofluorimeter in binding buffer (20 mM Tris-HCl (pH 7.5), 5 mM MgCl2,
0.1 mM dithiothreitol, 50 µg/ml bovine serum albumin and
indicated concentration of NaCl or sodium acetate) at 25 °C.
Different NF- The Apparent Affinity of the p50 Homodimer for Nonspecific DNA Is
Higher Than Observed for the p65 Homodimer--
The filter binding
assay is useful for surveying many different sites, but a solution
binding assay is preferred for detailed binding studies. Fluorescence
polarization has been used to study protein association with
fluorescently labeled oligonucleotide-binding sites. Labeled DNA alone
shows low fluorescence polarization in solution (typically ~60-80
millipolarization units). Upon addition of protein, the polarization
increases to ~180-200 millipolarization units for the protein-DNA
complex. Previous experiments in this laboratory have shown that the
cellular activity of the human Ig p50 and p65 DNA Binding Affinity Is Sensitive to the Ionic Strength
and Anionic Component in the Buffer--
The ionic dependence of
NF-
Because the p50 homodimer can bind to nonspecific DNA with an
appreciable affinity, the ionic strength dependence of this interaction
could also be determined. Apparent DNA binding affinity of p50 binding
for a non-NF- Binding of p50 or p65 to the In this report, we assess the biochemical characteristics of
NF- While studying DNA-binding site selectivity, the interaction with
nonspecific DNA has also been addressed. The data show that p50 binds
to nonspecific DNA with a higher apparent affinity than p65 under the
conditions tested. We can define specificity of binding to a DNA
sequence as the ratio of the apparent affinity for a specific
DNA-binding site sequence divided by the apparent affinity for
nonspecific DNA. For p50, this comparison is complicated by the finding
that the ionic strength dependence for specific and nonspecific binding
sites is different. The data show that the specificity of p50 for a
specific sequence decreases as ionic strength increases, because
nonspecific binding is less sensitive to ionic strength than specific
binding. A comparison of p50 specificity at several sodium acetate
concentrations shows that at low ionic strength (~50 mM)
the specificity of binding is between 100 and 4000 depending on the
site, but a physiological ionic strength the specificity is
significantly lower (5-10). The significance of this result is
unclear, however, these experiments were done using short DNA-binding
sites (18 nucleotides) and we have observed that the apparent affinity
of DNA binding is very sensitive to binding site length (data not
shown). It is possible that the apparent affinity dependence on length
is a consequence of the nonspecific affinity and is a mechanism used by
p50 to find specific DNA-binding sites. Thus, in the context of a
longer DNA sequence the apparent affinity of a specific site might
increase, which would increase the overall specificity. However,
further analysis of this interaction would be required to test this hypothesis.
The selectivity of different forms of NF- Thus, these data are consistent with a model of NF-
B. This factor is found in cells as a dimer which can contain any
two members of the Rel family of proteins (p50, p65, p52, c-Rel, and
RelB). The different dimers show distinct preferences for DNA-binding site sequences. To understand the relationship between the DNA binding
properties of the dimer forms and transcriptional activation, the
physical properties of the complexes of p50 and p65 with DNA have been
analyzed. Comparison of apparent DNA binding affinity showed
differences in selectivity of DNA-binding site sequence. The ionic
strength dependence of apparent binding affinity has shown that the
number of ionic interactions in the protein-DNA complex depends on the
DNA-binding site sequence and the dimer form, which are consistent with
changes in the structure of the protein-DNA complex. Using a
fluorescent technique to measure DNA structure changes, protein binding
does not appear to alter the structure of the DNA-binding site within
the limits of detection. These results are consistent with a change in
protein structure that may result in activation differences due to
alternative interactions with other transcription proteins.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B has been shown to activate
transcription from many genes involved in the immune response (for review, see Ref. 1) and from several viral promoters
(HIV1 (2) and cytomegalovirus
(3)). The central role for NF-
B in inflammation has been confirmed
in mice lacking the p50 or the RelB subunit of NF-
B. These animals
show severe alterations in their response to immune challenge (4, 5).
In addition, p65-deficient B- and T-cells show severe reductions in
cellular activation (6). The active DNA binding form of NF-
B is a
dimer and can consist of any combination of five different NF-
B/Rel protein subunits (p50, p52, p65, c-Rel, and RelB) (1, 7). Many previous
studies have shown that dimers of the different monomeric forms show
differences in sequence selectivity. Early studies looking at p50 and
p65 DNA binding specificity suggested that the p65 subunit extended the
specificity of p50 (8). In studies of DNA-binding site selection,
Kunsch et al. (9) have shown defined selectivities for each
dimer form using electrophoretic mobility shift assays. Perkins
et al. (10) have shown that subunit composition could
influence transcriptional activation in transfection assays in Jurkat
T-cells. It has also been shown that the 3'-half site of a NF-
B
element has a profound effect on the species of NF-
B dimer that
binds to that site (11). Finally, Schmid et al. (12) have
shown that the p50 and p49 subunits of NF-
B have distinct binding
properties and function differently on different DNA-binding sites.
Thus, there is clear evidence that there are differences between the
protein-DNA complexes that depend on the dimer form and the DNA
sequence in the complex. However, there have been few studies to
identify and characterize what the structural differences could be
between these complexes.
-sheet structure
(14). Because, the differences in activity observed when bound to
alternate sites is likely to be biologically significant, we have
analyzed the physical characteristics of p50/p50, p65/p65, and p50/p65
dimer binding to several DNA-binding site sequences.
B-DNA complexes. The data show
that the p50 homodimer can bind to nonspecific DNA with a higher
apparent affinity than the p65 homodimer. Also, the NF-
B-DNA
interaction is sensitive to the anion in the buffer, which suggests
that ions are released from the protein upon binding. Finally the
number of ions released upon complex formation is dependent on the DNA
sequence of the binding site and the dimer form. This last result is
consistent with the hypothesis that the conformation of the protein-DNA
complex can vary with DNA-binding site sequence.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside for 1 h.
Induced cells were washed and resuspended in lysis buffer (20 mM Hepes (pH 7.5), 10 mM MgCl2,
20% glycerol, 0.1% Nonidet P-40, 1 mM dithiothreitol, 10 µg/ml DNase I, and 0.5 mM phenylmethylsulfonyl fluoride)
and sonicated. Cellular debris was removed by centrifugation at 45,000 × g for 10 min. Glutathione-agarose purification was done
as described by the manufacturer (Amersham Pharmacia Biotech). Homodimer binding experiments were done using the glutathione S-transferase (GST) fusion proteins without further
purification. Heterodimer binding experiments were carried out after
incubation of equimolar amounts of GSTp50 and GSTp65 for 30 min at
37 °C (19). TATA-binding protein was a gift of Dr. B. Markham
(Parke-Davis Pharmaceutical Research).
-interferon
NF-
B site 20-mer; 10 nM) was mixed with variable amounts
of the competitor DNA prior to the addition of the GST-Rel fusion
proteins. DNA-binding site sequences used are shown in Table
I. Competitor DNA concentration varied
from zero to 10 µM. Rel protein dimers (50 nM
p50 homodimer, p65 homodimer, or the p50/p65 heterodimer) were
incubated with the
-interferon probe and cold competitors in binding
buffer (10 mM Tris acetate (pH 7.4), 10 mM
magnesium acetate, 0.1 mM dithiothreitol, 0.1 mM EDTA, 5% dimethyl sulfoxide, and 50 µg/ml bovine
serum albumin) at 37 °C for 30 min. Following the incubation period,
each reaction was filtered through a nitrocellulose membrane (Immobilon
nitrocellulose 96-well filter plate; Millipore, Bedford, MA) which was
pre-equilibrated with filter buffer (10 mM Tris acetate (pH
7.4), 10 mM magnesium acetate, 0.1 mM EDTA, 5%
dimethyl sulfoxide). Each filter plate was then washed with filter
buffer and dried. Filter plates were counted using a Microbeta 1450 liquid scintillation counter (Wallac, Gaithersburg, MD). The degree of
competition was determined as the percentage of specific counts
retained on the filter in the presence of competitor compared with that
in the absence of competitor. Each experimental point was done in
triplicate and the average and error are reported for representative
experiments (average error was less than 5%). The half-maximal
concentration of competition was determined by nonlinear least squares
fitting of the data sets to a simple logistic plus slope using the
Origin analysis software package (MicroCal, MA).
NF-
B site sequence variants used in this study
-interferon, human
Ig-
, and HIV-binding site were synthesized with a single primary
amine (Aminolink; ABI) at the 5' end of the 18-mer using an ABI 294 DNA
synthesizer. The primary amine was then conjugated to fluorescein using
NHS-fluorescein (Molecular Probes). The fluorescein-conjugated
oligonucleotide was then purified from unreacted oligonucleotide using
gel electrophoresis. DNA was removed from the gel slice by crush and
soak in 10 mM Tris-HCl (pH 7.5), 1 mM EDTA
buffer. Double stranded DNA-binding site was then prepared by
reanealing to an unlabeled complementary oligonucleotide and again
purified by gel electrophoresis. The annealed binding site was then
used without further purification at a concentration of 2 nM for subsequent binding experiments unless otherwise
noted. Polarization was measured using a Beacon 2000 fluorescence
polarization system (PanVera, Madison, WI). Experiments were done in
polarization binding buffer (20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 0.1 mM dithiothreitol, 50 µg/ml bovine serum albumin and indicated concentration of NaCl or
sodium acetate) at 37 °C. Labeled binding site was added to 0.5 ml
of buffer in 10 × 75-mm tubes and the initial polarization
reading was taken. Protein aliquots were then added to the tube and
additional readings were taken until the readings did not change
(within 2 min) and the last 2 readings were averaged in the data shown.
The data from these experiments was plotted and fit to a hyperbola
using the nonlinear curve fitting functions of Origin analysis software package (MicroCal, MA).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B Forms Show Different Selectivity for DNA-binding
Sites--
Previous studies have shown that the alternative dimer
forms prefer different DNA-binding site sequences (9) that can effect transcriptional activation
(10).2 We have analyzed the
relative affinities of several DNA-binding sites for p50/p50, p65/p65,
or p50/p65 using purified fusion proteins and defined flanking
sequences. Fig. 1 shows data for p65
homodimer and 3 different competitor DNA-binding sites. The data have
been normalized to the concentration required to inhibit binding to 50% of the highest affinity competitor (Table
II). As expected from previous studies,
the order of apparent affinities for p50 homodimer is different from
that of p65 homodimer. The apparent affinity for p65 homodimer binding
to any of these sites varies over a 30-fold concentration range, while
the range of apparent affinity for p50 homodimer with the same
DNA-binding sites is less than 10-fold. The p50/p65 heterodimer order
of apparent affinity is similar to that of p65, however, the range of
apparent affinities for the p50/p65 heterodimer is smaller than that of
p65 homodimer. Thus, in this set of binding sites, the p65 monomer
seems to define the selectivity for the p50/p65 heterodimer complexes.
Also, the smaller difference in apparent affinity observed for p50
homodimer, compared with p65 homodimer, suggests that p65 binding is
more sensitive to DNA-binding site sequence than p50, for the
DNA-binding sites tested.

View larger version (16K):
[in a new window]
Fig. 1.
Selectivity for DNA-binding sites by
different NF-
B dimer forms. Homodimer of
p65 was incubated with labeled
-interferon probe and increasing
concentration of cold competitor was added to the reaction as described
under "Experimental Procedures." Competitor titration for p65
homodimer-
-interferon complex with
-interferon
(circles), hu Ig
(squares), and HIV long
terminal repeat (triangles).
Comparison of DNA-binding site preference between rel-protein dimers
,
-interferon, and the HIV
NF-
B DNA-binding sites are very different depending on the dimer
composition,3 so these sites
were chosen for examination. As shown in Fig. 2A, increasing the protein
concentration increases the observed fluorescence polarization. This
change can be observed for the three forms of NF-
B that have been
tested (p50/p50, p50/p65, and p65/p65). For each site the starting
polarization value of free DNA site was constant, however, the three
sites did show slightly different polarization in the absence of
protein (Ig
= ~95, HIV = ~90, and interferon = ~110). The polarization value of free DNA-binding site has been
subtracted from each data point for analysis. The data from the filter
binding experiments showed that there was less of a change in affinity
with binding site for p50 than observed for p65. This observation can
be interpreted to suggest that p50 is less binding site selective than
p65. Since selectivity is related to the difference between the
affinity of the protein to nonspecific sites compared with that for
specific sites, the ability of p50 homodimer and p65 homodimer to bind to an oligonucleotide that does not contain a consensus NF-
B-binding site was measured. As shown in Fig. 2B, the fluorescence
polarization of the nonspecific DNA-binding site increased with
increasing concentration of p50 homodimer. A small change was observed
only at high concentrations of p65 homodimer, suggesting that, under these conditions, p50 homodimer shows a higher apparent affinity for
nonspecific DNA than p65 homodimer. These data can be compared with
binding to a specific site and under the conditions tested, the
difference between the binding affinity of p50 homodimer for a
nonspecific site compared with a specific site is approximately 100-1,000, while that for p65 homodimer binding affinity is at least
1,000-10,000.

View larger version (14K):
[in a new window]
Fig. 2.
A, NF-
B DNA binding can be measured
using fluorescence polarization. Recombinant NF-
B (p50 or p65)
was added to fluorescein labeled DNA-binding site (18-mer) as described
under "Experimental Procedures" at the protein concentrations
shown. B, the p50/p50 homodimer binds to a nonspecific
DNA-binding site with a higher apparent affinity than the p65/p65
homodimer. Polarization experiments were done, as described under
"Experimental Procedures," using a nonspecific (mutant)
NF-
B-binding site using either p50 homodimer (circles) or
p65 homodimer (squares).
B binding to the human Ig
,
-interferon, and the HIV NF-
B
DNA-binding sites have been determined. Since, the relationship between
the apparent dissociation constant and the ionic strength is related to
the net number of ions displaced during complex formation (21, 22),
differences in ionic strength dependence suggest differences in the
structure of the protein-DNA complex. To understand the physical
properties of the different protein-DNA complexes, the ionic strength
dependence of DNA binding was determined for each of the protein dimer
form and the different DNA-binding sites. The results from p50
titration of the
-interferon DNA-binding site are shown in Fig.
3 at increasing sodium acetate concentrations. It is clear from these results that increasing the
sodium acetate concentration increases the amount of protein required
to approach saturation of the binding site. These data have been fit to
determine the apparent dissociation constants KD,app. As described elsewhere (23), the
slope of the log K versus the log monovalent
cation is equal to m'
, where m' is the number of direct ionic
interactions and
represents the number of thermodynamically bound
cations to the polyanion. The log-log analysis for p50 or p65 homodimer
or the p50/p65 heterodimer with the human Ig
,
-interferon, or the
HIV NF-
B DNA-binding site is shown in Fig.
4. The slopes from the data determined
using the interferon (Fig. 4A) and HIV (Fig. 4B)
sites are consistently 3-4 (Table III),
for all of the protein forms tested. Interestingly, the human Ig
site (Fig. 4C) shows a difference in the slopes observed
with the p65 homodimer (3.4) compared with the p50 homodimer or the
p50/p65 heterodimer (6.0 and 6.1, respectively). These data suggest
that more ions are displaced upon complex formation with p50. Thus, the
complexes formed with the human Ig
site must be structurally
different in the complexes containing p50 compared with those formed
with p65 alone.

View larger version (15K):
[in a new window]
Fig. 3.
Ionic strength affects apparent affinity of
the NF-
B-DNA complex. Binding experiments are shown
for p50/p50 titration of the
-interferon DNA-binding site at
increasing sodium acetate concentrations (50 mM,
squares; 100 mM, circles; 150 mM triangles) as described under "Experimental
Procedures." The initial polarization has been subtracted from each
point so that the initial reading is zero to allow curve fitting.

View larger version (12K):
[in a new window]
Fig. 4.
Log-log analysis of apparent affinity
sensitivity to ionic strength for several
NF-
B-DNA complexes. Data are shown for
the
-interferon (A), HIV long terminal repeat
(B), hu Ig
/E-selectin (C), or nonspecific
(D) DNA-binding sites using p50/p50 (circles),
p65/p65 (triangles), or p50/p65 (squares). All
data were generated using standard conditions as described under
"Experimental Procedures."
Ionic strength dependence of NF-
B binding to specific and
nonspecific DNA binding sites
B-binding site were determined at several sodium
acetate concentrations and the results were analyzed in a log-log
analysis. As shown in Fig. 4D, the apparent affinity of p50
homodimer for nonspecific DNA shows a reduced dependence on ionic
strength compared with the specific site data (slope = 1.4). These
results suggest that the contacts in the nonspecific DNA complex are
not exactly the same as those found in the specific complex. Several
reports have suggested that the anionic component of the buffer can
effect binding affinity. In addition, the anion can also be found to
effect the slope in a log-log analysis, suggesting that some of the
ions displaced upon binding are anions (24, 25). Analysis of the effect
on the anionic component on p50 homodimer binding is shown in Fig.
5, however, similar data have been
obtained for p65 homodimer. Substitution of chloride for acetate
significantly reduces the apparent affinity of p50 homodimer for DNA.
However, the slope of the log-log analysis is the same for chloride or
acetate. Thus, although the apparent affinity of DNA binding is
affected the net number of ions displaced is unchanged.

View larger version (8K):
[in a new window]
Fig. 5.
NF-
B binding to DNA
is sensitive to the anion in the binding buffer. Apparent
dissociation constants were obtained in buffer containing varying
concentrations of NaCl or sodium acetate, as described under
"Experimental Procedures." The log of the apparent dissociation
constant is plotted versus the log of the monovalent cation
(Na+).
-Interferon or the Human Ig
Does
Not Significantly Effect Bending of the Site as Measured by
Fluorescence Resonance Energy Transfer--
Since the ionic strength
dependence data suggest that there is a difference in the structure of
the protein-DNA complex, the molecular change could be in a change in
the DNA, a change in the protein or both. NF-
B binding to DNA has
been shown to bend DNA or not bend DNA depending on the report and the
method of measurement. The structure of the DNA-binding site in
solution can be determined using fluorescence resonance energy transfer between a fluorescence donor and acceptor at opposite ends of the DNA,
as changes in the end to end distance of the oligonucleotide would be
expected to accompany bending (26-29). Using fluorescein and rhodamine
as fluorescence donor and acceptor, respectively, we have measured
changes in DNA bending of short oligonucleotides (18-mers) containing a
single DNA-binding site in solution. As a control for the technique, we
have also measured transfer using an oligonucleotide containing a
TATA-binding site and TBP, which is known to bend upon protein binding
(30). As shown in Fig. 6A, the
spectrum of the double-labeled TATA site DNA, in the absence of TBP,
shows a slight transfer as seen in the small peak at 600-620 nm.
Addition of TBP significantly increases the transfer to the acceptor
and increases the peak in this region. There is also a strong decrease
in the fluorescence associated with fluorescein, the donor, as is
expected with increased transfer efficiency. Since, a difference was
observed in the ionic strength dependence of p50-human Ig
and
interferon-binding site, these complexes were tested for changes in
fluorescence energy transfer. As shown, binding of p50 has no effect on
the overall fluorescence energy transfer observed for the human Ig
or the interferon DNA-binding site (Fig. 6, B and
C, respectively). These experiments are done under
conditions where binding occurs at the protein concentrations tested
and this has been verified using polarization. These data suggest that
protein binding to this oligonucleotide does not make a net change in
the end to end distance of the oligonucleotide. These results are
consistent with the hypothesis that the structure of the DNA molecule
does not change substantially in these experiments.

View larger version (10K):
[in a new window]
Fig. 6.
Fluorescence resonance energy transfer (FRET)
to assess changes in DNA structure upon NF-
B
binding. Oligonucleotide binding sites were 5'-labeled with
fluorescein (donor) and rhodamine (acceptor) to measure changes in
distance due to structural changes in the DNA. Experiments were done at
10 nM p50, or 35 nM TBP and 2 nM
DNA-binding site. A, TBP binding to TATA-binding site.
B, NF-
B binding to
-intereferon, or C, hu
Ig
/E-selectin site upon addition of p65. Emission spectra are shown
in the absence of protein (solid line) or presence of
protein (dashed line).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B-DNA complex formation with several different sites. These analysis has lead to several conclusions. The p50 homodimer shows less
selectivity of DNA-binding site sequence than the p65 homodimer. Also,
the ionic strength dependence of complex formation is dependent on both
the NF-
B dimer form and the DNA-binding site sequence. Finally, the
apparent affinity of the NF-
B protein for DNA is influenced by the
anionic component of the buffer. This type of physical data, along with
models of the protein from x-ray crystallographic studies is necessary
for understanding the determinants of DNA binding specificity and how
they relate to the structure of the protein-DNA complex.
B has been previously
described (9). Since the amino acid sequences of the monomers are
different, it was assumed that the selectivity arose exclusively from
different amino acid-nucleotide base contacts. Recent descriptions of
the structures of NF-
B-DNA complexes have shown that many hydrogen
bonds are made between the protein monomer and the bases in the
DNA-binding site (13-16). Five amino acids in the p50 monomer appear
to make direct hydrogen bonds to bases and two of these are different
between p50 and p65 (His67
Ala; and Lys244
Arg) allowing for differences in hydrogen bonding patterns. The
reported structures for Rel family proteins (13-16) show that the
major DNA recognition amino acids are found on a loop between two
-sheet structures. In the absence of DNA, this loop has been suggested to be flexible since it is not contained in a defined secondary structure motif. These data suggest that the DNA-binding site
of Rel family proteins is likely to be flexible enough to allow some
movement when associated to DNA-binding site sequences other than those
that are found in the crystal structures. Recently, the crystal
structure of the p65-DNA complex has been described to have structural
differences in the DNA-binding domains of the two monomers (16). The
ionic strength dependence of the affinity of a protein for DNA is
related to the number of ions released to solvent upon complex
formation (22). If the number of ions released changes, it may be
related to a change in the structure of the protein. The change in the
ionic strength dependence of NF-
B-DNA complex formation described in
this report, suggest that the structure of the p50-DNA complex
containing either the
-interferon or the hu Ig
sites are
different. These results are consistent with the structural changes
observed in the p65 homodimer crystals. Thus, this data provides
physical evidence for flexibility in the DNA-binding site of p50 that
depends on the DNA-binding site sequence. In addition the data suggests
that, along with different amino acid contacts, the structure of the protein may be altered when bound to different DNA-binding site sequences.
B binding to DNA
that allows some variations in the DNA-binding domain of the protein to
accommodate different DNA-binding site sequences. This model might
explain why only some NF-
B DNA-binding sites promote cooperative
interactions with other transcription factors or accessory proteins
like high mobility group-I(Y) (31). It is also possible that the
alternative structures are associated with NF-
B transcriptional
activity directly, as some strong p65 homodimer DNA-binding sites are
found to be very poor activators of transcription (32). Therefore, the
alternative structures of NF-
B complexes may add another level of
regulation to transcription by this complex by using the DNA-binding
site as an allosteric effector of NF-
B activity.
| |
ACKNOWLEDGEMENTS |
|---|
I thank Drs. Stephen Hunt and Gary McMaster for support during this project and Dr. W. Thomas Mueller for production of the recombinant p50 and p65.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 734-622-5090;
Fax: 734-622-5970; E-mail: joseph.menetski@wl.com.
2 J. B. Marine and J. P. Menetski, manuscript in preparation.
3 J. B. Marine and J. P. Menetski, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HIV, human immunodeficiency virus; GST, glutathione S-transferase; TBP, TATA-binding protein; hu, human.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Lenardo, M. J., and Baltimore, D. (1989) Cell 58, 227-229[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Nabel, G., and Baltimore, D. (1987) Nature 326, 711-713[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Niller, H. H.,
and Hennighausen, L.
(1991)
Nucleic Acids Res.
19,
3715-3721 |
| 4. | Sha, W. C., Liou, H. C., Tuomanen, E. I., and Baltimore, D. (1995) Cell 80, 321-330[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A., and Bravo, R. (1995) Cell 80, 331-340[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Doi, T. S.,
Takahashi, T.,
Taguchi, O.,
Azuma, T.,
and Obata, Y.
(1997)
J. Exp. Med.
185,
953-961 |
| 7. | Gilmore, T. D. (1992) Cancer Surv 15, 69-87[Medline] [Order article via Infotrieve] |
| 8. | Urban, M. B., and Baeuerle, P. A. (1991) New Biol. 3, 279-288[Medline] [Order article via Infotrieve] |
| 9. |
Kunsch, C.,
Ruben, S. M.,
and Rosen, C. A.
(1992)
Mol. Cell. Biol.
12,
4412-4421 |
| 10. |
Perkins, N. D.,
Schmid, R. M.,
Duckett, C. S.,
Leung, K.,
Rice, N. R.,
and Nabel, G. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1529-1533 |
| 11. |
Muroi, M.,
Muroi, Y.,
Yamamoto, K.,
and Suzuki, T.
(1993)
J. Biol. Chem.
268,
19534-19539 |
| 12. |
Schmid, R. M.,
Liptay, S.,
Betts, J. C.,
and Nabel, G. J.
(1994)
J. Biol. Chem.
269,
32162-32167 |
| 13. | Muller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L., and Harrison, S. C. (1995) Nature 373, 311-317[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Ghosh, G., van Duyne, G., Ghosh, S., and Sigler, P. B. (1995) Nature 373, 303-310[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Cramer, P., Larson, C. J., Verdine, G. L., and Muller, C. W. (1997) EMBO J. 16, 7078-7090[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Chen, Y. Q., Ghosh, S., and Ghosh, G. (1998) Nat. Struct. Biol. 5, 67-73[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Chen, F. E., Huang, D. B., Chen, Y. Q., and Ghosh, G. (1998) Nature 391, 410-413[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Perkins, N. D.,
Agranoff, A. B.,
Pascal, E.,
and Nabel, G. J.
(1994)
Mol. Cell. Biol.
14,
6570-6583 |
| 19. |
Duckett, C. S.,
Perkins, N. D.,
Kowalik, T. F.,
Schmid, R. M.,
Huang, E. S.,
Baldwin, A. S., Jr.,
and Nabel, G. J.
(1993)
Mol. Cell. Biol.
13,
1315-1322 |
| 20. | Riggs, A. D., Suzuki, H., and Bourgeoss, S. (1970) J. Mol. Biol. 48, 67-83[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | deHaseth, P. L., Lohman, T. M., and Record, M. T., Jr. (1977) Biochemistry 16, 4783-4790[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Record, M. T., Jr., Anderson, C. F., and Lohman, T. M. (1978) Q. Rev. Biophys. 11, 103-178[Medline] [Order article via Infotrieve] |
| 23. | Record, M. T., Jr., Lohman, M. L., and De Haseth, P. (1976) J. Mol. Biol. 107, 145-158[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Menetski, J. P.,
Varghese, A.,
and Kowalczykowski, S. C.
(1992)
J. Biol. Chem.
267,
10400-10404 |
| 25. | Leirmo, S., Harrison, C., Cayley, D. S., Burgess, R. R., and Record, M. T., Jr. (1987) Biochemistry 26, 2095-2101[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Gohlke, C.,
Murchie, A. I.,
Lilley, D. M.,
and Clegg, R. M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11660-11664 |
| 27. |
Heyduk, E.,
Heyduk, T.,
Claus, P.,
and Wisniewski, J. R.
(1997)
J. Biol. Chem.
272,
19763-197670 |
| 28. | Parkhurst, K. M., Brenowitz, M., and Parkhurst, L. J. (1996) Biochemistry 35, 7459-7465[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Heyduk, T., and Lee, J. C. (1992) Biochemistry 31, 5165-5171[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Starr, D. B., Hoopes, B. C., and Hawley, D. K. (1995) J. Mol. Biol. 250, 434-446[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Thanos, D., and Maniatis, T. (1992) Cell 71, 777-789[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Casolaro, V.,
Georas, S. N.,
Song, Z.,
Zubkoff, I. D.,
Abdulkadir, S. A.,
Thanos, D.,
and Ono, S. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11623-11627 |
This article has been cited by other articles:
![]() |
P. K. Bhavsar, M. B. Sukkar, N. Khorasani, K.-Y. Lee, and K. F. Chung Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-{kappa}B FASEB J, June 1, 2008; 22(6): 1807 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Trainor, R. Ghirlando, and M. A. Simpson GATA Zinc Finger Interactions Modulate DNA Binding and Transactivation J. Biol. Chem., September 1, 2000; 275(36): 28157 - 28166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Baert, C. Beaudoin, L. Coutte, and Y. de Launoit ERM Transactivation Is Up-regulated by the Repression of DNA Binding after the PKA Phosphorylation of a Consensus Site at the Edge of the ETS Domain J. Biol. Chem., January 4, 2002; 277(2): 1002 - 1012. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |